Abstract:Abstract Abstract 2337 The nucleosome remodeling and deacetylase (NuRD) complex is involved in gene repression and normal hematopoiesis. In embryonic stem (ES) cells, NuRD complex directly maintains the self-renewal from lineage commitment. Murine models with defects in NuRD complex present with increased hematopoietic stem/progenitor cells (HSPCs). Several transcriptional factors (TFs), such as SALL4, FOG1, BCL11A, BCL11B, ZNF521 use a conservative 12 amino acid domain to recruit NuRD components for targeted gene repression. In this study, we plan to test the hypothesis that by blocking the interaction between NuRD and its TFs, we can phenocopy its knockdown effects on human HSPC. Human cord blood (CB) CD34+ cells were purified, and treated with peptide with the NuRD interacting sequences (wt-pep) or its controls mutant peptide (mut-pep) or scramble peptide (scr-pep). In vitro and in vivo assays were performed to evaluate whether wt-pep treatment can maintain or expand human cord blood HSPCs, which were further characterized as CD34+CD90+ and CD34+CD38-CD90+ sub-population with known repopulating potential after ex vivo culture. First we observed wt-pep treated CB CD34+ (1×104) cultures with cytokines (SCF, Flt3 ligand, IL-3 and IL-6) yielded 10.6 times greater numbers of CD34+CD90+ cells (Fig 1) and 19.3 times greater numbers of CD34+CD38-CD90+ as compared to the cultures containing cytokines with scr-pep after 6 days of culture (p<0.05). Colony formation assay demonstrated wt-pep treated cells gave mainly rise to large colonies, while scr-pep treated cells generated high proportion of small colonies, 8 days after plating (p<0.05). Treatment of CB CD34+ cells with wt-pep resulted in an increase in total colony-forming cell (CFC) content compared to other control groups, 14 days after plating (p<0.005). Then, to determine the most contributed to populations, Lin-CD34+CD38+CD90±, Lin-CD34+CD38-CD90± populations were fractionally sorted and treated with wt-pep. While the expansion rate of Lin-CD34+CD38+CD90± were too low to evaluate, wt-pep treated Lin-CD34+CD38-CD90+ and Lin-CD34+CD38-CD90- cells gave rise to 79.3% and 52.7% of CD34+CD90+ cells, respectively. In addition, Lin-CD34+CD38-CD90 + cells gave rise to much more CD34+CD38- population in wt-peptide treated cells as compared with scr-peptide treated cells (44.0%, 16.2% respectively) and almost all of these cells co-expressed CD90. These data suggested that both Lin-CD34+CD38-CD90± cells treated with wt-peptide could give rise to CD34+CD90+ as well as CD34+CD38-CD90+ cells. In addition, CD34+CD38-CD90+ cells seemed more contributed than CD34+CD38-CD90- cells for expansion of CD34+38-CD90+ cells. Based on in vitro experiment results, we investigated immunodeficient (SCID) repopulating activity (SRA) to determine efficacy of wt-pep to HSPCs in vivo. We observed that mice transplanted the progeny of 1×104 CB CD34+ cells treated with wt-pep (n=5) had higher degree of human cell chimerism (0.38%) than that with scr-peptide (0%) (n=5) at 4 weeks in peripheral blood. The 8 weeks chimerism of wt-peptide treated progeny (13.6%; n=5) were greater than scr-peptide treated progeny (1.88%; n=5) (Fig 2; p < 0.005) and also greater than unmanipulated CD34+ cells (1×104) (0.09%; n=3) (Fig 2; p < 0.05). In addition, these mice (n=5) demonstrated that multilineage differentiation. We further analyzed transcription levels of several HSPC related genes, which were compared between CB CD34+ cells treated with wt-peptide and scramble peptide. Significantly higher transcript levels were detected for HoxB4 (p < 0.05), GATA 2 (p < 0.05) and Evi1 (p < 0.05) and lower levels were detected for PTEN (p < 0.05) by real time quantitative RT-PCR in wt-peptide expanded cells as compared with scr-pep cultures. Unlike embryonic stem cells, human HSPC can not be maintained ex vivo in a culture condition. The limit in source cells has greatly hampered the field of HSPC research. Optimizing ex vivo HSPC expansion culture condition not only can facilitate basic research on these cells, but also can be translated into clinical applications such as enhancement of CB engraftment and gene therapy. Our study demonstrates a novel peptide approach for ex vivo expansion of a unique CD34+CD90+ and CD34+CD38-CD90+ population with increased engraftment potential. Future studies will reveal whether the same condition can beapplied to HSPC culture for gene therapy. Disclosures: No relevant conflicts of interest to declare.

Human Hematopoietic Stem Cell Homing and Engraftment Promoted by Glucocorticoid Induced Chromatin Remodeling

Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment

Down Regulation Of Cxc Chemokine Receptor 3 Impedes The Ability Of Anti-Cxcr3 Antibody To Block Graft-Versus-Host Disease

Inhibition of HDAC5-Mediated P65 Deacetylation Enhances Human Cord Blood Hematopoietic Stem Cell Homing and Engraftment in NSG Mice

Progress Towards Improving Homing and Engraftment of Hematopoietic Stem Cells for Clinical Transplantation

Neutralizing Negative Epigenetic Regulation by HDAC5 Enhances Human Haematopoietic Stem Cell Homing and Engraftment

Interaction with Human Stromal Cells Enhances CXCR4 Expression and Engraftment of Cord Blood Lin-CD34-Cells Via Wnt Signaling.

A Novel Approach in Expanding CD34+CD90+ and CD34+CD38-CD90+ Cells Associated with Enhanced in Vivo Repopulating Potential.

The Role Of Sdf-1/Cxcr4 In The Procession Of Auto-Stem Cell Transplantation Of Multiply Myeloma Patients.

Transient regulation of RNA methylation in human hematopoietic stem cells promotes their homing and engraftment

Enhancing Human Cord Blood Hematopoietic Stem Cell Engraftment by Targeting Nuclear Hormone Receptors

Pulse Activation of Retinoic Acid Receptor Enhances Hematopoietic Stem Cell Homing by Controlling CXCR4 Membrane Presentation

Enhancing human cord blood hematopoietic stem cell engraftment by targeting nuclear hormone receptors.

Recombinant Human Granulocyte Colony-Stimulating Factor Significantly Decreases the Expression of CXCR3 and CCR6 on T Cells and Preferentially Induces T Helper Cells to a T Helper 17 Phenotype in Peripheral Blood Harvests.

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Chemical Mutagenesis of a GPCR Ligand: Detoxifying “Inflammo-Attraction” to Direct Therapeutic Stem Cell Migration

Abstract 2181: A Novel CXCR4 Antagonist Strongly Mobilizes Hematopoietic Stem Cells in Vivo

Targeting the Retinoid X Receptor Pathway Prevents and Ameliorates Murine Chronic Graft-Versus-Host Disease

Molecular Regulators of Chemotaxis in Human Hematopoietic Stem Cells

In Vivo Cell Tracking Reveals the Pattern of Neutrophil Tissue Distribution at Baseline and in Response to Glucocorticoid Treatment

Granulocyte colony-stimulating factor directly acts on mouse lymphoid-biased but not myeloid-biased hematopoietic stem cells